[{"Assets_0_Q2_USD":224376000.0,"CommonStockSharesOutstanding_0_Q2_shares":30853000.0,"NetIncomeLoss_1_Q2_USD":-14473000.0,"NetIncomeLoss_2_Q2_USD":-36466000.0,"StockholdersEquity_0_Q2_USD":211697000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]